Product Information
NIKKI 3 MG-0.02 MG TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.1895 per EA under NDC 68180088673. Its NADAC has been published 342 times since Feb 5, 2020.
FDA first approved this application on May 27, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180088673
Classification
Generic
Dosage Form
KIT
Effective Date
8/19/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA201661FDA Approved
5/27/2014
TE Code
AB
On Market Since
11/30/2019
Price Statistics
The NADAC for NIKKI 3 MG-0.02 MG TABLET has been published 342 times since Feb 5, 2020, and over the history we have for it it has declined 55.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1895 per EA |
|---|---|
| All-time high | $0.4650 (Sep 16, 2020) |
| All-time low | $0.1278 (Nov 20, 2024) |
| 52-week high | $0.1933 |
| 52-week low | $0.1538 |
| Median price | $0.2744 |
| Average price | $0.2791 |
| Largest weekly change | -32.1% (Nov 20, 2024) |
| Weeks tracked | 342 |
| Tracking since | Feb 5, 2020 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 21% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of NIKKI 3 MG-0.02 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for NIKKI 3 MG-0.02 MG TABLET, manufactured by Lupin Pharmaceuticals Inc., is $0.1895 per EA (NDC 68180088673), effective Aug 19, 2026.
How has the price of NIKKI 3 MG-0.02 MG TABLET changed over time?
Over the history we have for it, the NADAC for NIKKI 3 MG-0.02 MG TABLET has declined 55.9%. It has been tracked across 342 weekly CMS publications since Feb 5, 2020.
What are the highest and lowest recorded NADAC prices for NIKKI 3 MG-0.02 MG TABLET?
Since Feb 5, 2020, the NADAC for NIKKI 3 MG-0.02 MG TABLET has ranged from a low of $0.1278 (Nov 20, 2024) to a high of $0.4650 (Sep 16, 2020), with a median of $0.2744 per EA.
Are there cheaper alternatives to NIKKI 3 MG-0.02 MG TABLET?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DROSPIRENONE-EE 3-0.03 MG TAB, is $0.1492 per EA — about 21% below NIKKI 3 MG-0.02 MG TABLET.
Who manufactures NIKKI 3 MG-0.02 MG TABLET?
NIKKI 3 MG-0.02 MG TABLET (NDC 68180088673) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.